Safety Surveillance Adviser
CurrentEnsuring patient safety for Semaglutide in clinical development and on the market:▪️ Signal detection and signal management▪️ Responsible for clinical trial closure activities on the FLOW trial▪️ Critical analysis and medical evaluation of emerging aggregate safety data▪️ Contribute to regulatory submission documents, periodic aggregate reports, and health authority interactions▪️ Project lead for a team of advisers investigating a new safety signal, ensuring timely delivery of results and communication to stakeholders▪️ Close collaboration with other functional areas within Novo Nordisk